kynurenic acid has been researched along with oxidopamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brotchie, JM; Fox, SH; Moser, B | 1 |
| Illes, P; Poelchen, W; Sieler, D; Wirkner, K | 1 |
| Rassoulpour, A; Schwarcz, R; Wu, HQ | 1 |
| Chen, L; Gao, GD; Ge, SN; Jia, D; Wang, JL; Yan, ZQ; Yang, C; Zhang, JR; Zhu, JL | 1 |
4 other study(ies) available for kynurenic acid and oxidopamine
| Article | Year |
|---|---|
Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dopamine Agonists; Excitatory Amino Acid Antagonists; Indoles; Kynurenic Acid; Locomotion; Male; Microinjections; Oxidopamine; Parkinson Disease, Secondary; Pyridines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Substantia Nigra; Sympatholytics; Urea | 1998 |
Co-transmitter function of ATP in central catecholaminergic neurons of the rat.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Catecholamines; Electric Stimulation; Evoked Potentials; Excitatory Postsynaptic Potentials; Guanethidine; Idazoxan; In Vitro Techniques; Kynurenic Acid; Male; Membrane Potentials; Neurons; Norepinephrine; Oxidopamine; Picrotoxin; Pons; Pyridoxal Phosphate; Rats; Rats, Wistar; Synaptic Transmission; Thionucleotides | 2001 |
Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Astrocytes; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Extracellular Space; Kynurenic Acid; Levodopa; Male; Neostriatum; Neurons; Neurotoxins; Oxidopamine; Parkinson Disease; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Substantia Nigra | 2002 |
Decreased HCN2 expression in STN contributes to abnormal high-voltage spindles in the cortex and globus pallidus of freely moving rats.
Topics: Animals; Antiparkinson Agents; Cardiovascular Agents; Cerebral Cortex; Disease Models, Animal; Down-Regulation; Excitatory Amino Acid Antagonists; Globus Pallidus; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Indoles; Kynurenic Acid; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Subthalamic Nucleus; Wakefulness | 2015 |